提升的同类半氨酸水平和大脑缩变化作为选阿尔茨海默病的标志物:病例系列
Ram Prakash Sah1, C S Vidya1, Pratibha Pereira2
1Department of Anatomy, JSS Medical College, JSS Academy of Higher Education and Research, Mysore, India.
Annals of geriatric medicine and research
|December 17, 2023
概括
高水平的homocysteine可能表明阿尔茨海默病 (AD) 的风险. 这项研究探讨了血清homocysteine作为潜在的阿尔茨海默病早期查标记,将其与大脑缩相关联.
科学领域:
- 神经学 神经学
- 生物化学 生物化学
- 老年病的医生 老年病的医生
背景情况:
- 阿尔茨海默病 (AD) 是全球痴呆的主要原因,其特点是认知能力下降和大脑缩.
- 超homocysteinemia (homocysteine>15μmol/L) 是阿尔茨海默病,脑血管问题和大脑缩的危险因素.
- 神经成像显示了与年龄相关的变化和AD患者的脑血管损伤.
研究的目的:
- 为了研究血清类型半氨酸,叶酸和维生素B12水平与阿尔茨海默病中大脑缩之间的关系.
- 评估血清类固醇蛋白作为阿尔茨海默病早期查生物标志物的潜力.
主要方法:
- 这一病例系列分析了阿尔茨海默病患者的生物化学标记物 (血清同型半氨酸,叶酸,维生素B12).
- 使用神经成像,与皮层-皮下白质缩程度相关联的生物化学标记水平.
主要成果:
- 在阿尔茨海默病患者中观察到 homocysteine 水平升高.
- 研究人员发现,同类半氨酸水平与大脑缩之间存在相关性.
- 需要进一步的研究来确认同类氨酸作为可靠的早期AD标志物.
结论:
- 血清homocysteine可以作为早期阿尔茨海默病查的潜在代用标记物.
- 监测homocysteine,叶酸和维生素B12水平可能有助于AD风险评估.
- 这项研究强调了代谢因素与AD神经退行症之间的联系.
相关概念视频
Alzheimer's Disease: Overview
492
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
492
Alzheimer's Disease: Treatment
195
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
195
Dementia
115
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
115


